Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Liabilities and Shareholders Equity (2018 - 2025)

AVITA Medical's Liabilities and Shareholders Equity history spans 8 years, with the latest figure at $56.4 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 29.25% year-over-year to $56.4 million; the TTM value through Dec 2025 reached $247.8 million, down 28.37%, while the annual FY2025 figure was $56.4 million, 29.25% down from the prior year.
  • Liabilities and Shareholders Equity reached $56.4 million in Q4 2025 per RCEL's latest filing, down from $63.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $128.1 million in Q1 2021 to a low of $56.4 million in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $93.2 million, with a median of $95.0 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 67.4% in 2021, then tumbled 33.81% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $116.0 million in 2021, then fell by 15.3% to $98.3 million in 2022, then increased by 13.61% to $111.6 million in 2023, then decreased by 28.6% to $79.7 million in 2024, then decreased by 29.25% to $56.4 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Liabilities and Shareholders Equity are $56.4 million (Q4 2025), $63.7 million (Q3 2025), and $58.1 million (Q2 2025).